Evaluation of Seropositivity after Standard Doses of Vaccination against SARS-CoV-2 in Early Breast Cancer Patients Receiving Adjuvant Treatment
Jinyong Kim, Euijin Chang, Song Yi Park, Dae-Won Lee, Chang Kyung Kang, Pyoeng Gyun Choe, Nam Joong Kim, Myoung-don Oh, Wan Beom Park, Kyung-Hun Lee, Seock-Ah Im
doi: https://doi.org/10.1101/2022.07.23.22277888
Jinyong Kim
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Euijin Chang
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Song Yi Park
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Dae-Won Lee
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Chang Kyung Kang
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Pyoeng Gyun Choe
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Nam Joong Kim
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Myoung-don Oh
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Wan Beom Park
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
Kyung-Hun Lee
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
2Cancer Research Institute, Seoul National University, Seoul, Korea
Seock-Ah Im
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
2Cancer Research Institute, Seoul National University, Seoul, Korea
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted July 24, 2022.
Evaluation of Seropositivity after Standard Doses of Vaccination against SARS-CoV-2 in Early Breast Cancer Patients Receiving Adjuvant Treatment
Jinyong Kim, Euijin Chang, Song Yi Park, Dae-Won Lee, Chang Kyung Kang, Pyoeng Gyun Choe, Nam Joong Kim, Myoung-don Oh, Wan Beom Park, Kyung-Hun Lee, Seock-Ah Im
medRxiv 2022.07.23.22277888; doi: https://doi.org/10.1101/2022.07.23.22277888
Evaluation of Seropositivity after Standard Doses of Vaccination against SARS-CoV-2 in Early Breast Cancer Patients Receiving Adjuvant Treatment
Jinyong Kim, Euijin Chang, Song Yi Park, Dae-Won Lee, Chang Kyung Kang, Pyoeng Gyun Choe, Nam Joong Kim, Myoung-don Oh, Wan Beom Park, Kyung-Hun Lee, Seock-Ah Im
medRxiv 2022.07.23.22277888; doi: https://doi.org/10.1101/2022.07.23.22277888
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2656)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12248)
- Forensic Medicine (10)
- Gastroenterology (763)
- Genetic and Genomic Medicine (4114)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2666)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (853)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6538)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)